Quality of life with adjuvant gefitinib versus vinorelbine plus cisplatin in patients with completely resected stage II–IIIA (N1–N2) EGFR-mutant non-small-cell lung cancer: Results from the ADJUVANT (CTONG1104) study
Keyword(s):
Stage Ii
◽
Keyword(s):
2012 ◽
Vol 20
(6)
◽
pp. 1941-1948
◽
Keyword(s):
2015 ◽
Vol 33
(5)
◽
pp. 522-523
◽
Keyword(s):
Keyword(s):
2003 ◽
Vol 21
(16)
◽
pp. 3007-3008
◽
Keyword(s):
Keyword(s):
2009 ◽
Vol 4
(9)
◽
pp. 1075-1082
◽
Keyword(s):
2013 ◽
Vol 4
(4)
◽
pp. 82
◽
2016 ◽
Vol 3
(2)
◽